Merck & Co took a hit on May 14, 2025, as Citigroup downgraded its rating from "Buy" to "Neutral" and slashed its price ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck is facing an awkward encore as one of the worst-performing blue chip stocks in 2025, sliding 23.3% year-to-date.

We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck ...

We recently published a list of the Best Income Stocks to Invest in Now. In this article, we are going to take a look at ...

C4 Therapeutics, Inc.’s CCCC share price has surged by 12.77%, which has investors questioning if this is right time to sell.

It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated ...

Merck’s stock was gaining after the drugmaker beat quarterly earnings expectations again and maintained its full-year outlook despite additional costs related to tariffs. Photo: Getty Images ...

We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

The stock's payout ratio is around 45%, which suggests that even if its earnings decline this year, Merck's dividend will still be safe given the comfortable buffer. Energy stock NextEra has ...

It operates through two segments, Pharmaceutical and Animal Health. The 52-week range of Merck stock price was $75.93 to $134.63. Merck's dividend yield is 4.06%. It paid $3.24 per share in ...